Deltex Medical Group plc
DEMG.L · LSE
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | -28.4% | 9.9% | -5.8% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 63.3% | 70.4% | 65.6% | 64.5% |
| EBITDA | -£0 | -£0 | -£0 | -£0 |
| % Margin | -56.4% | -33% | -33.1% | -22.1% |
| Net Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | -72.2% | -46.3% | -42.8% | -33.3% |
| EPS Diluted | -0.001 | -0.002 | -0.002 | -0.002 |
| % Growth | 35.3% | 0% | -13.3% | – |
| Operating Cash Flow | -£0 | -£0 | -£0 | -£0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£0 | -£0 | -£0 | -£0 |